Esperion Therapeutics (ESPR) Institutional Ownership $0.85 -0.06 (-6.13%) Closing price 04:00 PM EasternExtended Trading$0.86 +0.01 (+1.41%) As of 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Esperion Therapeutics (NASDAQ:ESPR)CurrentInstitutional OwnershipPercentage47.39%Number ofInstitutional Buyers(last 12 months)69TotalInstitutional Inflows(last 12 months)$41.07MNumber ofInstitutional Sellers(last 12 months)37TotalInstitutional Outflows(last 12 months)$105.61M Get ESPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Esperion Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ESPR Institutional Buying and Selling by Quarter Esperion Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Jane Street Group LLC180,227$260K0.0%-48.3%0.091% 5/16/2025 Goldman Sachs Group Inc.1,527,286$2.20M0.0%-44.5%0.771% 5/16/2025 Jones Financial Companies Lllp192,743$278K0.0%N/A0.097% 5/16/2025 Two Seas Capital LP6,930,871$9.98M0.3%-40.0%3.498% 5/16/2025 AQR Capital Management LLC61,887$89K0.0%-68.7%0.031% 5/15/2025 Graham Capital Management L.P.487,735$702K0.0%+153.5%0.246% 5/15/2025 State of Wyoming89,936$130K0.0%+93.8%0.045% 5/14/2025 MetLife Investment Management LLC74,786$108K0.0%-36.5%0.038% 5/14/2025 CW Advisors LLC46,300$74K0.0%N/A0.023% 5/14/2025 Summit Financial LLC65,194$94K0.0%+40.1%0.033% Get the Latest News and Ratings for ESPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Esperion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/14/2025 Wellington Management Group LLP761,980$1.10M0.0%+36.0%0.385% 5/12/2025 Meridian Wealth Management LLC20,000$29K0.0%N/A0.010% 5/12/2025 Nuveen LLC3,087,700$4.45M0.0%N/A1.558% 5/12/2025 Virtu Financial LLC35,909$52K0.0%-72.8%0.018% 5/12/2025 Invesco Ltd.255,480$368K0.0%+161.1%0.129% 5/12/2025 Connor Clark & Lunn Investment Management Ltd.822,618$1.19M0.0%-11.7%0.415% 5/9/2025 Deutsche Bank AG125,784$181K0.0%-24.3%0.063% 5/9/2025 Headlands Technologies LLC38,447$55K0.0%-84.9%0.019% 5/7/2025 SLT Holdings LLC50,000$72K0.1%+66.7%0.025% 5/7/2025 Foundations Investment Advisors LLC50,172$72K0.0%+66.3%0.025% 5/7/2025 Mackenzie Financial Corp123,115$177K0.0%-14.1%0.062% 5/5/2025 Private Advisor Group LLC40,106$58K0.0%+33.2%0.020% 5/2/2025 Victory Capital Management Inc.23,622$34K0.0%-86.4%0.012% 5/2/2025 Summit Wealth Group LLC293,000$422K0.1%+86.6%0.148% 4/29/2025 Bank of New York Mellon Corp415,141$598K0.0%-2.9%0.210% 4/22/2025 Synergy Asset Management LLC31,000$45K0.0%+3,496.3%0.016% 4/8/2025 Rhumbline Advisers236,030$340K0.0%-4.4%0.119% 3/24/2025 Wellington Management Group LLP560,276$1.23M0.0%-7.1%0.283% 2/20/2025 Mackenzie Financial Corp143,252$315K0.0%+116.1%0.073% 2/17/2025 Woodline Partners LP1,503,746$3.31M0.0%-33.0%0.763% 2/17/2025 Two Sigma Advisers LP3,616,200$7.96M0.0%+0.4%1.835% 2/17/2025 Two Sigma Investments LP3,540,361$7.79M0.0%-2.3%1.797% 2/17/2025 State of Wyoming46,410$102K0.0%-40.3%0.024% 2/17/2025 Rafferty Asset Management LLC37,056$82K0.0%N/A0.019% 2/17/2025 ProShare Advisors LLC62,549$138K0.0%+75.2%0.032% 2/17/2025Nuveen Asset Management LLC3,119,253$6.86M0.0%+48.6%1.583% 2/17/2025 Millennium Management LLC829,885$1.83M0.0%-75.6%0.421% 2/17/2025 Gotham Asset Management LLC11,977$26K0.0%-49.8%0.006% 2/17/2025 Graham Capital Management L.P.192,415$423K0.0%-19.0%0.098% 2/17/2025 Deutsche Bank AG166,220$366K0.0%-89.3%0.084% Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo…2/17/2025 D. E. Shaw & Co. Inc.251,592$554K0.0%+152.7%0.128% 2/17/2025 Crestline Management LP28,745$63K0.0%N/A0.015% 2/17/2025 Bayesian Capital Management LP65,900$145K0.0%N/A0.033% 2/17/2025 Bank of America Corp DE1,629,980$3.59M0.0%+45.1%0.827% 2/17/2025 BNP Paribas Financial Markets153,212$337K0.0%+24.2%0.078% 2/14/2025 Northern Trust Corp1,540,084$3.39M0.0%+4.5%0.782% 2/14/2025 Indaba Capital Management L.P.3,000,000$6.60M3.2%-91.1%1.523% 2/14/2025 Susquehanna Fundamental Investments LLC65,260$144K0.0%N/A0.033% 2/14/2025 Virtus ETF Advisers LLC137,120$302K0.1%+21.2%0.070% 2/14/2025 Price T Rowe Associates Inc. MD123,896$273K0.0%+15.3%0.063% 2/14/2025 MetLife Investment Management LLC117,732$259K0.0%+65.7%0.060% 2/13/2025 Wasatch Advisors LP24,482,258$53.86M0.3%+4.9%12.425% 2/13/2025 XTX Topco Ltd24,494$54K0.0%-84.3%0.012% 2/13/2025 Barclays PLC359,235$791K0.0%+16.0%0.182% 2/13/2025 CenterBook Partners LP1,306,259$2.87M0.2%-58.0%0.663% 2/13/2025 Raymond James Financial Inc.44,658$98K0.0%N/A0.023% 2/13/2025 Renaissance Technologies LLC578,800$1.27M0.0%-36.7%0.294% 2/13/2025 Invesco Ltd.97,833$215K0.0%+15.5%0.050% 2/13/2025 Rhenman & Partners Asset Management AB1,915,000$4.21M0.4%-3.0%0.972% 2/12/2025 Rangeley Capital LLC107,000$235K0.2%N/A0.054% 2/12/2025 Geode Capital Management LLC4,339,948$9.55M0.0%+0.2%2.203% 2/12/2025 Headlands Technologies LLC255,066$561K0.1%+55.0%0.129% 2/12/2025 Diametric Capital LP354,010$779K0.5%-46.9%0.180% 2/12/2025 Summit Financial LLC46,528$102K0.0%+18.2%0.024% 2/12/2025 Alliancebernstein L.P.159,260$350K0.0%-12.5%0.081% 2/12/2025 Wellington Management Group LLP560,276$1.23M0.0%-7.1%0.284% 2/12/2025 JPMorgan Chase & Co.2,454,216$5.40M0.0%+18.6%1.246% 2/11/2025 Prudential Financial Inc.33,570$74K0.0%-32.3%0.017% 2/11/2025 Corebridge Financial Inc.93,944$207K0.0%-7.0%0.048% 2/11/2025 Vanguard Group Inc.11,715,748$25.78M0.0%-10.2%5.946% 2/11/2025 Virtu Financial LLC132,234$291K0.0%N/A0.067% 2/11/2025 Platinum Investment Management Ltd.840,052$1.85M0.1%-23.1%0.426% 2/11/2025 Intech Investment Management LLC81,385$179K0.0%+43.0%0.041% 2/10/2025 Cibc World Markets Corp17,683$39K0.0%N/A0.009% 2/10/2025 Corient Private Wealth LLC50,745$112K0.0%-68.2%0.026% 2/10/2025 Connor Clark & Lunn Investment Management Ltd.932,008$2.05M0.0%+31.0%0.473% 2/7/2025 SLT Holdings LLC30,000$66K0.1%N/A0.015% 2/6/2025 Raymond James Financial Inc.44,658$98K0.0%N/A0.023% 2/6/2025 Victory Capital Management Inc.173,083$381K0.0%+602.8%0.088% 2/4/2025 Summit Wealth Group LLC157,000$345K0.1%+292.5%0.080% 2/3/2025 Sigma Planning Corp190,441$419K0.0%+1,455.8%0.097% 1/31/2025 J.W. Cole Advisors Inc.30,200$66K0.0%N/A0.015% 1/24/2025 China Universal Asset Management Co. Ltd.41,779$92K0.0%N/A0.021% 1/22/2025 Foundations Investment Advisors LLC30,172$66K0.0%+48.6%0.015% 1/21/2025 SJS Investment Consulting Inc.25,000$55K0.0%N/A0.013% 1/17/2025 SG Americas Securities LLC151,482$333K0.0%+96.6%0.077% 12/26/2024 JPMorgan Chase & Co.2,069,117$3.41M0.0%+1.0%1.050% 12/19/2024 Principal Financial Group Inc.15,344$25K0.0%-24.9%0.008% 11/22/2024 Eaton Financial Holdings Company LLC44,030$73K0.0%N/A0.022% 11/19/2024 Barclays PLC309,671$510K0.0%+99.6%0.157% Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos11/16/2024 Geode Capital Management LLC4,331,314$7.15M0.0%+4.1%2.198% 11/15/2024 Barclays PLC309,671$510K0.0%+99.6%0.157% 11/15/2024 Public Employees Retirement System of Ohio367,373$606K0.0%N/A0.186% 11/15/2024 Anson Funds Management LP327,110$540K0.0%N/A0.166% 11/15/2024 XTX Topco Ltd156,300$258K0.0%-57.1%0.079% 11/15/2024 Wellington Management Group LLP602,936$995K0.0%+66.8%0.306% 11/15/2024 State Street Corp3,854,314$6.36M0.0%+2.7%1.956% 11/15/2024 Parkman Healthcare Partners LLC903,140$1.49M0.2%-21.1%0.458% 11/14/2024 Wasatch Advisors LP23,346,013$38.52M0.2%+38.4%11.848% 11/14/2024 MetLife Investment Management LLC71,050$117K0.0%+47.1%0.036% (Data available from 1/1/2016 forward) ESPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ESPR shares? During the previous two years, 126 institutional investors and hedge funds held shares of Esperion Therapeutics. The most heavily invested institutionals were Wasatch Advisors LP ($53.86M), Bellevue Group AG ($26.65M), Vanguard Group Inc. ($25.78M), Great Point Partners LLC ($12.86M), Two Seas Capital LP ($9.98M), Armistice Capital LLC ($9.57M), and Marshall Wace LLP ($9.55M).Learn more on ESPR's institutional investors. What percentage of Esperion Therapeutics stock is owned by institutional investors? 47.39% of Esperion Therapeutics stock is owned by institutional investors. Learn more on ESPR's institutional investor holdings. Which institutional investors have been buying Esperion Therapeutics stock? Of the 95 institutional investors that purchased Esperion Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wasatch Advisors LP ($7.86M), Bellevue Group AG ($5.74M), Vanguard Group Inc. ($3.69M), Armistice Capital LLC ($3.20M), Nuveen LLC ($3.09M), Marshall Wace LLP ($2.09M), and Monaco Asset Management SAM ($1.03M). How much institutional buying is happening at Esperion Therapeutics? Institutional investors have bought a total of 39,003,405 shares in the last 24 months. This purchase volume represents approximately $82.18M in transactions. Which Esperion Therapeutics major shareholders have been selling company stock? Of the 55 institutional investors that sold Esperion Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Indaba Capital Management L.P. ($30.75M), Two Seas Capital LP ($4.62M), Wasatch Advisors LP ($2.85M), Millennium Management LLC ($2.57M), Great Point Partners LLC ($2.21M), Platinum Investment Management Ltd. ($2.12M), and CenterBook Partners LP ($1.81M). How much institutional selling is happening at Esperion Therapeutics? Institutional investors have sold a total of 59,414,534 shares in the last 24 months. This volume of shares sold represents approximately $128.13M in transactions. Related Companies Xencor Institutional Ownership AbCellera Biologics Institutional Ownership ChromaDex Institutional Ownership KalVista Pharmaceuticals Institutional Ownership Replimune Group Institutional Ownership Bicycle Therapeutics Institutional Ownership AnaptysBio Institutional Ownership Cogent Biosciences Institutional Ownership Sionna Therapeutics Institutional Ownership Keros Therapeutics Institutional Ownership This page (NASDAQ:ESPR) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Esperion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Esperion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ESPR Stock Free ESPR Stock Alerts